Kymera Therapeutics (NASDAQ:KYMR) Shares Down 3.6%

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Rating)’s stock price was down 3.6% on Tuesday . The company traded as low as $25.09 and last traded at $25.35. Approximately 152,721 shares traded hands during trading, a decline of 70% from the average daily volume of 507,524 shares. The stock had previously closed at $26.29. Wall Street […]

Related Keywords

Hong Kong ,Zurcher Kantonalbank Zurich Cantonalbank ,Raymond James ,Nasdaq ,Kymera Therapeutics Inc ,Hong Kong Ltd ,Kymera Therapeutics Company Profile ,Advisors Asset Management Inc ,Credit Suisse Group ,Kymera Therapeutics ,Get Rating ,Suisse Group ,Therapeutics Stock Down ,Kong Ltd ,Asset Management ,Kantonalbank Zurich Cantonalbank ,Quantbot Technologies ,Kymera Therapeutics Daily ,Nasdaq Kymr ,Kymr ,Medical ,Stocks ,Technicals ,